Ambit Biosciences Corp (AMBI)

15.60
0.26 1.69
NASDAQ : Health Care
Prev Close 15.34
Open 15.40
Day Low/High 15.40 / 16.25
52 Wk Low/High 4.80 / 16.25
Volume 140.14K
Avg Volume 155.80K
Exchange NASDAQ
Shares Outstanding 18.00M
Market Cap 280.80M
EPS -1.02
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

SHAREHOLDER ALERT – The Law Offices Of Vincent Wong Investigates The Board Of Directors Of Ambit Biosciences Corporation In Connection With The Sale Of The Company To Daiichi Sankyo Company, Ltd.

SHAREHOLDER ALERT – The Law Offices Of Vincent Wong Investigates The Board Of Directors Of Ambit Biosciences Corporation In Connection With The Sale Of The Company To Daiichi Sankyo Company, Ltd.

The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of Ambit Biosciences Corporation (NasdaqGM:AMBI) (“Ambit Biosciences”) in connection with the sale of the ...

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation Of Ambit Biosciences Corporation In Connection With The Sale Of The Company

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation Of Ambit Biosciences Corporation In Connection With The Sale Of The Company

Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Ambit Biosciences Corporation (“Ambit” or the “Company”) (Nasdaq: AMBI)...

It's True, Small-Cap Biotech Stocks Are Acting Badly These Days

It's True, Small-Cap Biotech Stocks Are Acting Badly These Days

For the past three months, small-cap biotech stocks have been underperforming the broader market.

SHAREHOLDER ALERT: Brower Piven Launches An Investigation Into The Proposed Sale Of Ambit Biosciences Corporation And Encourages Investors To Contact The Firm For Additional Information

SHAREHOLDER ALERT: Brower Piven Launches An Investigation Into The Proposed Sale Of Ambit Biosciences Corporation And Encourages Investors To Contact The Firm For Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of...

SHAREHOLDER ALERT – The Law Offices Of Vincent Wong Investigates The Board Of Directors Of Ambit Biosciences Corporation In Connection With The Sale Of The Company To Daiichi Sankyo Company, Ltd.

SHAREHOLDER ALERT – The Law Offices Of Vincent Wong Investigates The Board Of Directors Of Ambit Biosciences Corporation In Connection With The Sale Of The Company To Daiichi Sankyo Company, Ltd.

The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of Ambit Biosciences Corporation (NasdaqGM:AMBI) (“Ambit Biosciences”) in connection with the sale of the ...

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation Of Ambit Biosciences Corporation In Connection With The Sale Of The Company

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation Of Ambit Biosciences Corporation In Connection With The Sale Of The Company

Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Ambit Biosciences Corporation (“Ambit” or the “Company”) (Nasdaq: AMBI)...

INVESTOR ALERT: Levi & Korsinsky, LLP Launches Investigation Of The Board Of Directors Of Ambit Biosciences Corporation Concerning The Fairness Of The Sale Of The Company To Daiichi Sankyo Company, Ltd.

INVESTOR ALERT: Levi & Korsinsky, LLP Launches Investigation Of The Board Of Directors Of Ambit Biosciences Corporation Concerning The Fairness Of The Sale Of The Company To Daiichi Sankyo Company, Ltd.

Levi & Korsinsky is investigating the Board of Directors of Ambit Biosciences Corporation (“Ambit” or “the Company”) (NasdaqGM: AMBI) for possible breaches of fiduciary duty and other violations of...

Law Offices Of Howard G. Smith Announces Investigation Of Ambit Biosciences Corporation

Law Offices Of Howard G. Smith Announces Investigation Of Ambit Biosciences Corporation

Law Offices of Howard G. Smith announces that it is investigating potential claims against the Board of Directors of Ambit Biosciences Corporation (“Ambit” or the “Company”) (NASDAQ:AMBI) related to...

Law Firm Kirby McInerney LLP Investigating Potential Claims On Behalf Of Ambit Biosciences Corporation Stockholders

Law Firm Kirby McInerney LLP Investigating Potential Claims On Behalf Of Ambit Biosciences Corporation Stockholders

Kirby McInerney LLP is investigating potential claims against Ambit Biosciences Corporation (“Ambit Biosciences” or the “Company”) (NASDAQ:AMBI) concerning the proposed acquisition of the Company by ...

Why Ambit Biosciences (AMBI) Stock Is Soaring Today

Why Ambit Biosciences (AMBI) Stock Is Soaring Today

Shares of Ambit Biosciences (AMBI) surged Monday after Japanese drug maker Daiichi Sankyo (DSNKY) agreed to purchase the company for approximately $315 million.

SHAREHOLDER ALERT: Brower Piven Launches An Investigation Into The Proposed Sale Of Ambit Biosciences Corporation And Encourages Investors To Contact The Firm For Additional Information

SHAREHOLDER ALERT: Brower Piven Launches An Investigation Into The Proposed Sale Of Ambit Biosciences Corporation And Encourages Investors To Contact The Firm For Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Investigates The Board Of Directors Of Ambit Biosciences Corporation Regarding The Fairness Of The Sale Of The Company To Daiichi Sankyo Company, Ltd.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Investigates The Board Of Directors Of Ambit Biosciences Corporation Regarding The Fairness Of The Sale Of The Company To Daiichi Sankyo Company, Ltd.

Levi & Korsinsky is investigating the Board of Directors of Ambit Biosciences Corporation (“Ambit” or “the Company”) (NasdaqGM: AMBI) for possible breaches of fiduciary duty and other violations of...

AMBIT SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Investigate Buyout By Daiichi Sankyo

AMBIT SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Investigate Buyout By Daiichi Sankyo

Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Ambit...

Daiichi Sankyo To Acquire Ambit Biosciences

Daiichi Sankyo To Acquire Ambit Biosciences

Lead Compound, Quizartinib, Will Further Build Daiichi Sankyo Oncology Pipeline

Daiichi Sankyo To Acquire Ambit Biosciences

Daiichi Sankyo To Acquire Ambit Biosciences

Lead Compound, Quizartinib, Will Further Build Daiichi Sankyo Oncology Pipeline

Ambit Biosciences Becomes Oversold (AMBI)

Ambit Biosciences Becomes Oversold (AMBI)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

RSI Alert: Ambit Biosciences (AMBI) Now Oversold

RSI Alert: Ambit Biosciences (AMBI) Now Oversold

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.